Literature DB >> 33657296

Diffuse Large B-Cell Lymphoma.

Laurie H Sehn1, Gilles Salles1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33657296     DOI： 10.1056/NEJMra2027612

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  50 in total

1.  Impact of TP53 Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell Therapy.

Authors:  Roni Shouval; Ana Alarcon Tomas; Joshua A Fein; Jessica R Flynn; Ettai Markovits; Shimrit Mayer; Aishat Olaide Afuye; Anna Alperovich; Theodora Anagnostou; Michal J Besser; Connie Lee Batlevi; Parastoo B Dahi; Sean M Devlin; Warren B Fingrut; Sergio A Giralt; Richard J Lin; Gal Markel; Gilles Salles; Craig S Sauter; Michael Scordo; Gunjan L Shah; Nishi Shah; Ruth Scherz-Shouval; Marcel van den Brink; Miguel-Angel Perales; Maria Lia Palomba
Journal:  J Clin Oncol       Date:  2021-12-03       Impact factor: 44.544

2.  Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience.

Authors:  Yu-Wen Wang; Xavier Cheng-Hong Tsai; Hsin-An Hou; Feng-Ming Tien; Jia-Hau Liu; Wen-Chien Chou; Bor-Sheng Ko; Yu-Wen Chen; Chien-Chin Lin; Chieh-Lung Cheng; Min-Yen Lo; Yun-Chu Lin; Li-Chun Lu; Shang-Ju Wu; Sung-Hsin Kuo; Ruey-Long Hong; Tai-Chung Huang; Ming Yao
Journal:  Ann Hematol       Date:  2021-11-11       Impact factor: 3.673

3.  APR-246 triggers ferritinophagy and ferroptosis of diffuse large B-cell lymphoma cells with distinct TP53 mutations.

Authors:  Yuheng Hong; Tianyuan Ren; Xiaoxuan Wang; Xia Liu; Yue Fei; Shen Meng; Xu Han; Cong Sun; Hongru Shen; Lanfang Li; Lihua Qiu; Zhengzi Qian; Shiyong Zhou; Huilai Zhang; Xianhuo Wang
Journal:  Leukemia       Date:  2022-07-14       Impact factor: 12.883

4.  Patterns of Use, Outcomes, and Resource Utilization among Recipients of Commercial Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed/Refractory Aggressive B Cell Lymphomas.

Authors:  Peter A Riedell; Wei-Ting Hwang; Loretta J Nastoupil; Martina Pennisi; Joseph P McGuirk; Richard T Maziarz; Veronika Bachanova; Olalekan O Oluwole; Jamie Brower; Oscar A Flores; Nausheen Ahmed; Levanto Schachter; Kharmen Bharucha; Bhagirathbhai R Dholaria; Stephen J Schuster; Miguel-Angel Perales; Michael R Bishop; David L Porter
Journal:  Transplant Cell Ther       Date:  2022-07-16

5.  Building the Bridge: Molecular Imaging Biomarkers for 21st Century Cancer Therapies.

Authors:  Mark A Sellmyer; Iris K Lee; David A Mankoff
Journal:  J Nucl Med       Date:  2021-08-26       Impact factor: 11.082

6.  A 9-LncRNA Signature for Predicting Prognosis and Immune Response in Diffuse Large B-Cell Lymphoma.

Authors:  Xiaoxuan Wang; Yaxiao Lu; Ziyi Liu; Yidan Zhang; You He; Cong Sun; Lanfang Li; Qiongli Zhai; Bin Meng; Xiubao Ren; Xudong Wu; Huilai Zhang; Xianhuo Wang
Journal:  Front Immunol       Date:  2022-07-06       Impact factor: 8.786

7.  Formation of Lymphoma Hybrid Spheroids and Drug Testing in Real Time with the Use of Fluorescence Optical Tweezers.

Authors:  Kamila Duś-Szachniewicz; Katarzyna Gdesz-Birula; Emilia Nowosielska; Piotr Ziółkowski; Sławomir Drobczyński
Journal:  Cells       Date:  2022-07-05       Impact factor: 7.666

Review 8.  Management of Extranodal Marginal Zone Lymphoma: Present and Upcoming Perspectives.

Authors:  Dominic Kaddu-Mulindwa; Lorenz Thurner; Konstantinos Christofyllakis; Moritz Bewarder; Igor Age Kos
Journal:  Cancers (Basel)       Date:  2022-06-19       Impact factor: 6.575

9.  Identification of CXCR4 Upregulation in Diffuse Large B-Cell Lymphoma Associated with Prognostic Significance and Clinicopathological Characteristics.

Authors:  Yi-An Zhang; Xue Yang; Jiamei Yao; Yuhong Ren; Peng Liu
Journal:  Dis Markers       Date:  2022-06-21       Impact factor: 3.464

10.  Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remission.

Authors:  Mazyar Shadman; Marcelo Pasquini; Kwang Woo Ahn; Yue Chen; Cameron J Turtle; Peiman Hematti; Jonathon B Cohen; Farhad Khimani; Siddhartha Ganguly; Reid W Merryman; Jean A Yared; Frederick L Locke; Nausheen Ahmed; Pashna N Munshi; Amer Beitinjaneh; Patrick M Reagan; Alex F Herrera; Craig S Sauter; Mohamed A Kharfan-Dabaja; Mehdi Hamadani
Journal:  Blood       Date:  2022-03-03       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.